Evidence map›Paper›PMID 27284318›Full record

ArticleExperimental and therapeutic medicine2016

Cardioprotective effect of notoginsenoside R1 in a rabbit lung remote ischemic postconditioning model via activation of the TGF-β1/TAK1 signaling pathway.

Zhi-Ru Ge, Mao-Chun Xu, Y U Huang, Chen-Jun Zhang, J E Lin, Chang-Wu Ruan

RetractedOpen access · diamondAbstract readRetracted Publication
In one paragraph

Article in Experimental and therapeutic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury.Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2023
    Review
  4. Review
  5. Protection of CAPE-pNOInflammation · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhi-Ru GeDepartment of Cardiology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, P.R. China.
Mao-Chun XuDepartment of Cardiology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, P.R. China.
Y U HuangDepartment of Cardiology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, P.R. China.
Chen-Jun ZhangDepartment of Cardiology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, P.R. China.
J E LinDepartment of Cardiology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, P.R. China.
Chang-Wu RuanDepartment of Cardiology, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, P.R. China.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacological postconditioning using cardioprotective agents is able to reduce myocardial infarct size. Notoginsenoside R1 (NG-R1), a phytoestrogen isolated from

Indexed as

apoptosis of myocardial cellsnotoginsenoside R1remote postconditioningTGF-β activated kinase 1transforming growth factor-β1

Identifiers

PMID27284318
PMCPMC4887923
OpenAlexW2326321122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.